Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019Original Research · 2021 · 8,335 citations
2Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhagePrognostic Study · 2006 · 1,169 citations
3Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient dataRisk Assessment · 2018 · 434 citations
4Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trialRCT · 2018 · 482 citations
5Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trialCohort Study · 2021 · 63 citations
6Mobile Stroke Units Facilitate Prehospital Management of Intracerebral HemorrhageOriginal Research · 2021 · 42 citations
7The ABCs of Measuring Intracerebral Hemorrhage VolumesOriginal Research · 1996 · 2,225 citations
8Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trialRCT · 2021 · 21 citations
9Degenerative cervical myelopathy: early detection and the potential for preventing disabilityThe Lancet Neurology · 2026
10Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysisThe Lancet Neurology · 2026

More from The Lancet Neurology

More from The University of Melbourne